[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Anvith_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::2414532469.png) The Indian Investor [@Anvith_](/creator/twitter/Anvith_) on x 19.2K followers
Created: 2025-07-23 14:34:34 UTC

🧬 Senores Pharma : Blockbuster Q1FY26 🔥 

▪️ PAT ⬆️ XX% at ₹21 Cr (YoY)
▪️ Revenue ⬆️ XX% at ₹138 Cr (YoY)
▪️ EBIDTA ⬆️ XX% at ₹34 Cr (YoY)
▪️ Regulated Markets Revenue ⬆️ XX% at ₹90 Cr (YoY) | EBITDA Margin: 35.5%.
▪️ Emerging Markets Revenue ⬆️ XX% at ₹29 Cr (YoY) | EBITDA Margin: 6%.
▪️Launched X own ANDA products     
▪️ Received approval for X in Regulated Markets.
▪️ Regulated Markets: XX Own commercial products, XX Approved ANDA, XX Pipeline.
▪️ Emerging Markets: XXX Registered products, XXX under Registration in 40+ countries.
▪️ CDMO/CMO segment scaling up with new contracts & increased customer share.
▪️ Positive Operating Cash Flow: ₹11 Cr in Q1 FY26.
▪️ X formulation facilities (US & India), X API facilities (India), strong R&D.
▪️ Targeting pan-India Branded Generics leadership by FY26 end.

#Senores #SenoresPharma #Q1FY26 #CDMO

![](https://pbs.twimg.com/media/GwjKBmyaoAAvn5B.jpg)

XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948028974212559323/c:line.svg)

**Related Topics**
[robust](/topic/robust)
[investment](/topic/investment)

[Post Link](https://x.com/Anvith_/status/1948028974212559323)